Medvantx’s Post

Simplify your post-op regimens with OSRX combination therapies. Our solutions mean fewer drops, simplified dosing, and improved overall satisfaction. See how we can help you make your practice more efficient and patient-friendly. 🌟💧👁️ #OSRX #CompoundingPharmacy #EyeCare #EyeCareInnovation #PracticeEfficiency *OSRX medications are not FDA approved and carry serious risks. Please click here: http://bit.ly/osrxmedrisks to view potential adverse events and contraindications.

The mystical land of USP <800> compliance can be a confusing, dark, and lonely place - and don't we know it! That's why Rpharmy created our very own Hazardous Drugs Resources page. This web page centralizes countless resources and references to guide you and your healthcare organization on the road to USP <800> compliance. Click below to access the link which contains a sample SBAR, access to BlackboxRX, NIOSH 2016 + 2020 resources, and more: https://loom.ly/_Qgnvxg #Rpharmy #HealthcareSoftware #Rhazdrugs #USP800 #Formulary #HealthSystemFormulary #Pharmacy

Ensuring the integrity of container closures is crucial for the safe packaging of injectable drugs. Don't miss out—sign up for our webinar, Sealed for Safety: A Deep Dive into Container Closure Integrity, and discover how to evaluate CCI to guarantee the highest quality for injectable medications. https://bit.ly/3XNaKWx

Looking forward to sharing how we can help you meet ISMP Guidelines at TSHP. Stop by for a demo -- Booth 508 -- and learn why more than 950 of the world's leading hospitals and over 15,000 operating rooms have made Safe Label System a standard of care. #standardofcare #safelabelsystem #wastelog #patientsafety #medicationsafety #syringelabel #tjcompliance #340B #chargecapture #Pharmacy #hospitalpharmacy

Ensuring the integrity of container closures is crucial for the safe packaging of injectable drugs. Don't miss out—sign up for our webinar, Sealed for Safety: A Deep Dive into Container Closure Integrity, and discover how to evaluate CCI to guarantee the highest quality for injectable medications. https://bit.ly/3zkW9Zb

What's New for Intelliview ➡️ Understanding Virginia's EMS Drug Kit Regulations: Insights from Guidance Document 110-41! Prepare your EMS agency for regulatory changes in Virginia with our new blog. Gain insights into the Drug Supply Chain Security Act's impact on EMS drug kit management and discover key points from Guidance Document 110-41 issued by the Virginia Board of Pharmacy. From hospital pharmacy exchanges to internal kit preparation, understand the intricacies of compliance and how our MedixSafe and IntelliView products can support your agency's journey. Read the full blog here: https://lnkd.in/eY87WBmf #EMSRegulations #FirstResponders #Healthcare

Stay updated with all things Rpharmy on our Safety First Blog! This go-to resource is filled with articles surrounding hazardous drug best practices, expert USP <800> tips, and the latest updates in the ever-changing world of pharmacy. Click the link below to start reading! 📝 https://loom.ly/2GF5FCk #Rpharmy #HealthcareSoftware #Formweb #USP800 #Formulary #HealthSystemFormulary #PharmacySafety #NurseSafety #HealthcareCompliance

Whether you are 25, 40, or 65, life is too short to spend it indoors, crouched over the toilet. Doctors trust Tasectan as the number one prescribed diarrhoea treatment. Why wouldn’t you? This treatment works fast to ensure that you can get back to spending quality time with your loved ones. #tasectan #austellpharmaceuticals #antidiarrhoealtreatment #diarrhoeatreatment

When faced with a drug shortage, what’s the etiology? PBM? GPO? FDA? Or is it something else? And why is there such a shortage of drugs manufactured domestically? This is a snapshot of one factory’s experience. Worth reading

Wegovy’s New Indication Turns Up Heat on Employers Sweating GLP-1 Costs: When the FDA approved Novo Nordisk’s Wegovy (semaglutide) for reducing the risk of serious heart problems, it paved the way for Medicare Part D plans to cover the drug. Industry experts also predict that the drug’s expanded indication will pressu... Read More #marketaccess #lifesciences #pbm